Literature DB >> 16677275

Transient effect of epoprostenol and sildenafil combined with iNO for pulmonary hypertension in congenital diaphragmatic hernia.

Daniele De Luca, De Luca Daniele, Enrico Zecca, Giovanni Vento, Maria Pia De Carolis, De Carolis Maria Pia, Constantino Romagnoli, Romagnoli Constantino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16677275     DOI: 10.1111/j.1460-9592.2006.01879.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


× No keyword cloud information.
  7 in total

1.  Looking beyond PPHN: the unmet challenge of chronic progressive pulmonary hypertension in the newborn.

Authors:  Candice D Fike; Judy L Aschner
Journal:  Pulm Circ       Date:  2013-11-19       Impact factor: 3.017

Review 2.  Can we improve outcome of congenital diaphragmatic hernia?

Authors:  L van den Hout; I Sluiter; S Gischler; A De Klein; R Rottier; H Ijsselstijn; I Reiss; D Tibboel
Journal:  Pediatr Surg Int       Date:  2009-09       Impact factor: 1.827

Review 3.  Sildenafil for the treatment of pulmonary hypertension in pediatric patients.

Authors:  Alice J Huddleston; Chad A Knoderer; Jennifer L Morris; Eric S Ebenroth
Journal:  Pediatr Cardiol       Date:  2009-08-25       Impact factor: 1.655

4.  Safety of epoprostenol and treprostinil in children less than 12 months of age.

Authors:  Chelsey M McIntyre; Brian D Hanna; Natalie Rintoul; E Zachary Ramsey
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 5.  Current Concepts in the Management of Congenital Diaphragmatic Hernia in Infants.

Authors:  Vasanth H S Kumar
Journal:  Indian J Surg       Date:  2015-05-30       Impact factor: 0.656

Review 6.  Life-threatening PPHN refractory to nitric oxide: proposal for a rational therapeutic algorithm.

Authors:  Feriel Fortas; Matteo Di Nardo; Nadya Yousef; Marc Humbert; Daniele De Luca
Journal:  Eur J Pediatr       Date:  2021-06-06       Impact factor: 3.183

7.  Changes in vasoactive pathways in congenital diaphragmatic hernia associated pulmonary hypertension explain unresponsiveness to pharmacotherapy.

Authors:  Daphne S Mous; Marjon J Buscop-van Kempen; Rene M H Wijnen; Dick Tibboel; Robbert J Rottier
Journal:  Respir Res       Date:  2017-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.